Der Nervenarzt

, Volume 81, Issue 11, pp 1383–1396 | Cite as

Somatoforme und funktionelle Störungen

CME Weiterbildung · Zertifizierte Fortbildung

Zusammenfassung

Somatoforme Beschwerden zeichnen sich durch anhaltende und subjektiv beeinträchtigende Körperbeschwerden aus, für die auch nach angemessener somatischer Diagnostik keine ausreichende organmedizinische Erklärung gefunden werden kann. Die Prävalenzraten somatoformer Beschwerden und Störungen sind vor allem in der Primärversorgung beträchtlich. Der Verlauf der Störung ist typischerweise chronisch, die Remissionsraten sind niedrig. Die Genese und Aufrechterhaltung somatoformer Beschwerden sind als multifaktoriell anzusehen. Die Klassifikation somatoformer Störungen wird aktuell kontrovers diskutiert; es ist von einer deutlichen Änderung der Kategorie im künftigen DSM-V auszugehen. Hinsichtlich der Psychotherapie somatoformer Störungen liegt empirische Evidenz für die Wirksamkeit kognitiv-behavioraler sowie psychodynamischer Therapieansätze vor. Die Pharmakotherapie hat eine nachgeordnete Bedeutung, kann aber bei ausgeprägter Komorbidität von Angst- oder depressiven Störungen sinnvoll sein.

Schlüsselwörter

Somatoforme Störungen Funktionelle Syndrome Klassifikation Diagnostik Therapie 

Somatoform disorders and functional somatic syndromes

Summary

Somatoform symptoms occur in the absence of clear organic pathology. Typically, such symptoms are long-lasting and disabling. Somatoform symptoms and disorders are highly prevalent in primary care. The course of somatoform disorders is mostly chronic, and remission rates are low. Multiple factors influence the development and perpetuation of somatoform disorders. Currently, there is strong debate about the classification of somatoform disorders, and it is very likely that there will be significant changes in the classification of somatoform disorders in the upcoming DSM-V. With regard to the psychotherapeutic treatment of somatoform disorders, there is empirical evidence for the efficacy of cognitive-behavioral as well as psychodynamic-interpersonal strategies. Pharmacotherapy plays a minor role, but it can be useful mainly in cases of comorbid depression or anxiety.

Keywords

Somatoform disorders Functional syndromes Classification Assessment Therapy 

Literatur

  1. 1.
    Burbaum C, Stresing AM, Fritzsche K et al (2010) Medically unexplained symptoms as a threat to patients‘ identity? A conversation analysis of patients‘ reactions to psychosomatic attributions. Patient Educ Couns 79:207–217CrossRefPubMedGoogle Scholar
  2. 2.
    Chioqueta AP, Stiles TC (2004) Suicide risk in patients with somatization disorder. Crisis 25:3–7PubMedGoogle Scholar
  3. 3.
    Creed F, Barsky A (2004) A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 56:391–408CrossRefPubMedGoogle Scholar
  4. 4.
    Creed F, Guthrie E, Fink P et al (2010) Is there a better term than „medically unexplained symptoms“? J Psychosom Res 68:5–8CrossRefPubMedGoogle Scholar
  5. 5.
    Dimsdale J, Creed F on behalf of the DSM-V Workgroup on Somatic Symptom Disorder (2009) The proposed diagnosis of somatic symptom disorders in DSM-V to replace somatoform disorders in DSM-IV – a preliminary report. J Psychosom Res 66:473–476CrossRefPubMedGoogle Scholar
  6. 6.
    Fallon BA (2004) Pharmacotherapy of somatoform disorders. J Psychosom Res 56:455–460CrossRefPubMedGoogle Scholar
  7. 7.
    Fink P, Hansen MS, Oxhøj ML (2004) The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res 56:413–418CrossRefPubMedGoogle Scholar
  8. 8.
    Fink P, Schröder A (2010) One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndrome and somatoform disorders. J Psychosom Res 68:415–425CrossRefPubMedGoogle Scholar
  9. 9.
    Fröhlich C, Jacobi F, Wittchen HU (2006) DSM-IV pain disorder in the general population. An exploration of the structure and threshold of medically unexplained pain symptoms. Eur Arch Psychiatry Clin Neurosci 256:187–196CrossRefPubMedGoogle Scholar
  10. 10.
    Garcia-Campayo J, Alda M, Sobradiel N et al (2007) Personality disorders in somatization disorder patients: a controlled study in Spain. J Psychosom Res 62:675–680CrossRefPubMedGoogle Scholar
  11. 11.
    Hasin D, Katz H (2007) Somatoform and substance use disorders. Psychosom Med 69:870–875CrossRefPubMedGoogle Scholar
  12. 12.
    Henningsen P, Fazekas C, Sharpe M (2010) Barriers to improving treatment. In: Creed F, Henningsen P, Fink P (Hrsg) Improving the management of medically unexplained symptoms, somatisation and bodily distress. Cambridge Univ Press, Cambridge (in press)Google Scholar
  13. 13.
    Henningsen P, Fink P, Rief W (2010) Terminology, classification and concepts, or: what exactly are we talking about? In: Creed F, Henningsen P, Fink P (Hrsg) Improving the management of medically unexplained symptoms, somatisation and bodily distress. Cambridge Univ Press, Cambridge(in press)Google Scholar
  14. 14.
    Henningsen P, Martin A (2008) Somatoforme Störungen. In: Herpertz SC, Caspar F, Mundt C (Hrsg) Störungsorientierte Psychotherapie. Urban & Fischer, München, S 541–559Google Scholar
  15. 15.
    Henningsen P, Sattel H, Gündel H et al (2010) Psychodynamic-interpersonal psychotherapy for patients with pain-predominant multisomatoform disorder: a randomized controlled trial. Manuscript submitted for publicationGoogle Scholar
  16. 16.
    Henningsen P, Zimmermann T, Sattel H (2003) Medically unexplained physical symptoms, anxiety, depression: a meta-analytic review. Psychosom Med 65:528–533CrossRefPubMedGoogle Scholar
  17. 17.
    Henningsen P, Zipfel S, Herzog W (2007) Management of functional somatic syndromes. Lancet 369:946–955CrossRefPubMedGoogle Scholar
  18. 18.
    Kapfhammer HP (2008) Somatoforme Störungen. Konzept, Klinik, Ätiopathogenese und Therapie. Nervenarzt 79:99–117CrossRefPubMedGoogle Scholar
  19. 19.
    Kapfhammer HP (2008) Somatoform Störungen. In: Holsboer F, Gründer G, Benkert O (Hrsg) Handbuch der Psychopharmakotherapie. Springer, Heidelberg, S 949–962Google Scholar
  20. 20.
    Kroenke K (2006) Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 60:335–339CrossRefPubMedGoogle Scholar
  21. 21.
    Lahmann C, Henningsen P, Noll-Hussong M, Dinkel A (2010) Somatoforme Störungen. Psychother Psychosom Med Psychol 60:227–236CrossRefPubMedGoogle Scholar
  22. 22.
    Lahmann C, Loew TH, Tritt K, Nickel M (2008) Efficacy of functional relaxation and patient education in the treatment of somatoform heart disorders: a randomized, controlled clinical investigation. Psychosomatics 49:378–385CrossRefPubMedGoogle Scholar
  23. 23.
    Lahmann C, Röhricht F, Sauer N et al (2010) Functional relaxation as complementary therapy in irritable bowel syndrome: a randomized, controlled clinical trial. J Altern Complement Med 16:47–52CrossRefPubMedGoogle Scholar
  24. 24.
    olde Hartmann TC, Borghuis MS, Lucassen PLBJ et al (2009) Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res 66:363–377CrossRefGoogle Scholar
  25. 25.
    Rief W, Broadbent E (2007) Explaining medically unexplained symptoms – models and mechanisms. Clin Psychol Rev 27:821–841CrossRefPubMedGoogle Scholar
  26. 26.
    Rief W, Treede RD, Schweiger U et al (2009) Neue Schmerzdiagnose in der deutschen ICD-10-Version. Nervenarzt 80:340–342CrossRefPubMedGoogle Scholar
  27. 27.
    Smith RC, Gardiner JC, Lyles JS et al (2005) Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Psychosom Med 67:123–129CrossRefPubMedGoogle Scholar
  28. 28.
    Sumathipala A (2007) What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 69:889–900CrossRefPubMedGoogle Scholar
  29. 29.
    Thomassen R, Hemert AM van, Huyse FJ et al (2003) Somatoform disorders in consultation-liaison psychiatry: a comparison with other mental disorders. Gen Hosp Psychiatry 25:8–13CrossRefPubMedGoogle Scholar
  30. 30.
    van der Feltz-Cornelis CM, Van Os TWDP, Van Marwijk HWJ, Leentjens AFG (2010) Effect of psychiatric consultation models in primary care. A systematic review and meta-analysis of randomized controlled trials. J Psychosom Res 68:521–533CrossRefGoogle Scholar
  31. 31.
    Voigt K, Nagel A, Meyer B et al (2010) Towards positive diagnostic criteria: A systematic review of somatoform disorder diagnoses and suggestions for future classification. J Psychosom Res 68:403–414CrossRefPubMedGoogle Scholar
  32. 32.
    Witthöft M, Hiller W (2010) Psychological approaches to origins and treatments of somatoform disorders. Annu Rev Clin Psychol 6:257–283CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Klinik und Poliklinik für Psychosomatische Medizin und PsychotherapieKlinikum rechts der Isar der TU MünchenMünchenDeutschland

Personalised recommendations